Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 6
2005 8
2006 11
2007 20
2008 16
2009 18
2010 14
2011 10
2012 21
2013 17
2014 7
2015 27
2016 24
2017 20
2018 14
2019 19
2020 19
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

248 results
Results by year
Filters applied: . Clear all
Page 1
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
Hussain M, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, Chi KN, Sartor O, Agarwal N, Olmos D, Thiery-Vuillemin A, Twardowski P, Roubaud G, Özgüroğlu M, Kang J, Burgents J, Gresty C, Corcoran C, Adelman CA, de Bono J; PROfound Trial Investigators. Hussain M, et al. N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955174 Clinical Trial.
Author Reply.
Chien TM, Lu YM, Chou YH, Wu WJ, Huang CN. Chien TM, et al. Among authors: wu wj. Urology. 2017 Jan;99:289-290. doi: 10.1016/j.urology.2016.09.008. Epub 2016 Sep 14. Urology. 2017. PMID: 27639789 No abstract available.
Biomarker Characterization by MALDI-TOF/MS.
Cho YT, Su H, Wu WJ, Wu DC, Hou MF, Kuo CH, Shiea J. Cho YT, et al. Among authors: wu wj. Adv Clin Chem. 2015;69:209-54. doi: 10.1016/bs.acc.2015.01.001. Epub 2015 Feb 17. Adv Clin Chem. 2015. PMID: 25934363 Review.
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.
Cha TL, Wu TT, Vogelzang NJ, Huang CY, Huang SP, Lin CC, Ou YC, Pang ST, Shen DH, Wu WJ, Chang WY. Cha TL, et al. Among authors: wu wj. J Formos Med Assoc. 2017 Nov;116(11):825-836. doi: 10.1016/j.jfma.2017.04.005. Epub 2017 Oct 16. J Formos Med Assoc. 2017. PMID: 29046247 Free article. Review.
248 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page